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The incubation of a ghost-free erythrocyte lysate with the oxidizmg agent phenylhydrazine resulted in both methemoglobin formation and release 
of iron in a desferrioxamine (DFO)-chelatable form. The released iron was diffusible, as shown by a dialysis carried out simultaneously with the 
incubation. When the dialysate was added to erythrocyte ghosts or to microsomes from liver or brain, lipid peroxidation developed m the 
membranes, indicating that the diffusible iron was in a redox active form. The addition of ATP to the lysate markedly increased both iron diffusion 
and lipid peroxidation m the membranes subsequently added to the dialysate. The possible implication of these data in some well known pathologies 
is discussed. 
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1. INTRODUCTION 
It is generally accepted that iron plays a central role 
in oxidative stress, both by generating harmful oxygen 
species and by promoting lipid peroxidation [l-4]. Since 
iron is transported and stored in specific proteins that 
prevent its reaction with reduced oxygen species, the 
problem concerned with redistribution of iron within 
the cell appears of major interest in studies of damage 
induced by oxidative stress. A number of reports have 
suggested that a low molecular weight iron pool is pres- 
ent in cells, as a transit pool, in which iron is probably 
chelated to citrate, amino acids and nucleotides [5-71. 
The possibility therefore exists that components of this 
pool represent the iron species catalytically active in 
initiating free radical reactions and lipid peroxidation 
under certain conditions. 
Previous studies from our laboratory [8] have shown 
that iron is released in a ‘free’ (desferrioxamine (DFO) 
chelatable) form when mouse erythrocytes are incu- 
bated with oxidizing agents such as phenylhydrazine, 
divicine, isouramil and acrolein. Iron is released from 
hemoglobin [9] and the release is accompanied by 
methemoglobin formation [8]. When the erythrocytes 
are severely depleted of glutathione (which occurs di- 
rectly with acrolein [lo] or after a short preincubation 
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with diethylmaleate with the other oxidants [8]). iron 
release is followed by peroxidation of membrane lipids 
and cellular lysis. If the cells are properly preloaded 
with DFO, lipid peroxidation and hemolysis are pre- 
vented [8]. It seems therefore that intracellular iron 
chelation prevents erythrocyte membrane damage, 
which suggests a primary role for iron in such damage. 
In view of the importance of the fact that under con- 
ditions of oxidative stress an agent is released which 
promotes oxidative reactions in the cell, we investigated 
in the present study whether the released iron is able to 
diffuse and act at a distance. The diffusion of iron in an 
active form from the site of its release could represent 
an important feature to postulate a role for delocalized 
iron in spreading out the oxidative damage in tissues 
where the release occurs. The results indicate that iron 
released from a hemolysate under conditions of oxida- 
tive stress diffuses into a dialysis tube in a redox active 
form capable of initiating oxidative reactions in cellular 
membranes. 
2. MATERIALS AND METHODS 
2.1. Muterials 
Desferrtoxamine (Desferal) was kindly supplied by Ciba-Geigy 
(Basel-Switzerland). Phenylhydrazine was from Merck. The dialysis 
tube was a section of Visking dialysis tubing 20/32 (Serva. Feinbio- 
chemica. Heidelberg, Germany; diameter 16 mm; wall strength 0 02 
mm; average diameter pore 1.552.0 nm; exclusion limit lO,OOO-20,000 
mol. wt.). Ultrafiltration membranes were from Amtcon (Centriflo, 
CF 25: exclusion limit 25,000 mol. wt.). ATP was from Sigma Chem. 
Electrophoresis standards and reagents were from Bio-Rad Laborato- 
ries (Richmond, CA). The solvents used for HPLC were of HPLC 
grade. All the other chemicals were of analytical grade. 
2.2. Preparation of ghost-free erythrocyte I_vsate 
Male Swiss albino mice (Nossan, Correzzana, Milan) weighing 255 
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35 g and maintained on a pellet diet (Nossan) were used. Blood was 
withdrawn from the abdominal aorta under ether anaesthesia nd 
heparinized. After centrifugation, the plasma and the buffy coat were 
removed and the erythrocytes washed three times with buffered phys- 
iological solution. Erythrocytes were lysed by addition of 4 ~01s. of 
hypotonic (10 mM) Tris-maleate buffer, pH 7.4. The lysate was centri- 
fuged (17,000 x g, 15 min) and the supernatant fraction and the ghosts 
separately recovered. To restore the physiological osmolarity, 140 mM 
NaCl was added to the ghost-free lysate. The hemoglobin concentra- 
tion measured as in [8] and expressed per heme, was 3.04 + O.lO,~moll 
ml. 
2.3. Membrane preparations 
The ghosts recovered from 1 ml of packed cells were washed three 
times by adding 7.5 ml of Na-phosphate buffer, pH 7.4, according to 
Dodge [ll]. The hemoglobin-free ghosts were washed in 140 mM 
NaCl. 10 mM Tris-maleate buffer, pH 7.4, and resuspended in the 
same buffer at a final concentration of 10 mg protein/ml. 
Liver or brain microsomes were prepared from 10% (w/v) liver or 
brain homogenates in 140 mM NaCI, 10 mM Tris-maleate buffer, pH 
7.4. The homogenates were centrifuged at 10,000 x g for 15 min and 
the supernatant fractions were centrifuged at 20.000 x g for 15 min. 
The post-lysosomal supernatants were centrifuged at 120,000 x g for 
60 mm. The microsomal pellet from liver or brain was resuspended 
in the same buffer at a final protein concentration of 10 mg/ml. Protein 
was determined according to Lowry [12]. 
2.4. Incubation procedure 
Twelve ml of ghost-free erythrocyte lysate were incubated in an 
Erlenmeyer flask into which a dialysis tube containing 4 ml of the same 
buffer used for the lysate preparation (140 mM NaCI, 10 mM Tris- 
maleate, pH 7.4) was dipped. The incubation was carried out aerobi- 
cally for 3 h in the presence of 1 mM phenylhydrazine. At the end of 
the incubation DFO-chelatable iron was determined in both the lysate 
and the contents of dialysis tube. Methemoglobin formation in the 
lysate was also determined [13]. Subsequently, the contents of the 
dialysis tube (0.9 ml) was added to the membrane (ghosts or micro- 
somes) suspensions (0.1 ml). The mixture was incubated aerobically 
for 1 h. Thiobarbituric acid-reactive substances (TBARS) formation 
was measured [14] as an index of lipid peroxidation. 
The electrophoretic analysis of ghost proteins was performed on 6% 
acrylamide gel (SDS-PAGE) according to Laemmli [15]. 
2.5. DFO-chelatable iron determmation 
DFO-chelatable iron was determined as previously reported [lo]. 
Briefly, at the end of the incubations aliquots of both lysate and 
contents of dialysis tube were withdrawn; 35pM DFO was added. The 
lysate was ultrafiltered by centrifugation in ultrafiltration cones (Cen- 
triflo). DFO-chelatable iron was measured in 0.5 ml of both ultrafil- 
trate and dialysate by HPLC as previously done [lo]. Preliminary 
experiments were performed to ascertain that the addition of DFO to 
the samples detects all iron present in the solutions even in presence 
of other chelators such as nitrilotriacetate (NTA) or ATP. 
ATP content of both whole erythrocytes and lysate was measured 
by HPLC according to Debetto and Bianchi [16]. 
3. RESULTS 
When a ghost-free erythrocyte lysate was incubated 
aerobically with phenylhydrazine, a release of iron was 
observed (Table I), as shown by the amount of DFO- 
chelatable iron detectable in the lysate (‘outside dialysis 
tube’). Concomitant with the release of iron, methemo- 
globin formation was seen. An iron release in whole 
erythrocyte lysate was also seen with acrolein [9]. In the 
present experiments ghosts were removed from the ly- 
sate to avoid any possible source of lipid peroxidation 
which could interfere with peroxidation of cellular 
membranes subsequently added to the dialysate (see 
below). 
When a dialysis tube containing only the buffer was 
dipped into the lysate from the start of the incubation, 
part of the released iron could be recovered in the dialy- 
sate (Table I, ‘inside dialysis tube’). When the contents 
of the dialysis tube were added to the ghosts, lipid per- 
oxidation developed in the ghosts (Table I). The electro- 
phoretic analysis of ghost proteins showed the appear- 
ance of high molecular weight aggregates (not shown), 
likely produced by cross-linking between proteins and 
peroxidized lipids. 
Table I 
Lipid peroxidation (TBARS) in erythrocyte ghosts, liver and brain microsomes exposed to diffusible iron (‘free iron’) released from a ghost-free 
erythrocyte lysate by phenylhydrazine (Phz) 
Conditions MetHb 
(nmol/ml) 
180 min 
‘Free iron’ TBARS TBARS TBARS 
(nmol/ml) produced by produced by produced by 
Ghosts Liver Bram 
Outside Inside (nmol/mg Pt) Microsomes Microsomes 
d.t. d.t. 60 min (nmohmg Pt) (nmol/mg Pt) 
60 min 60 min 
No additions (control) _ 0.6 f 0.1 0.7 f 0.1 0.9 f 0.1 1.9 f 0.2 1.3 f 0.4 
+ Lysate - Phz (control) 34.1 + 3.4 1.5 f 0.2 1.3 f 0.2 1.5 f 0.2 1.3 + 0.4 1.6 + 0.2 
- Lysate + Phz (control) _ 1.3 + 0.2 1.3 + 0.2 1.8 f 0.2 0.6 + 0.1 0.5 +_ 0.2 
+ Lysate + Phz (Exp.) 1126.4 f 71.9 14.1 + 1.8 6.0 f 0.5 6.0 f 0.6 5.2 f 0.1 8.2 f 2.0 
+ Lysate + Phz (Exp.) + DFO 1126.4 f 71.9 14.1 + 1.8 6.0 f 0.5 0.7 + 0.1 1.4 f 0.4 1.7 f 0.6 
The experimental f ask contained, in a final volume of 12 ml, a ghost-free erythrocyte lysate derived from 2.4 ml of packed cells, 140 mM NaCl 
and 10 mM Tris-maleate buffer, pH 7.4. Phenylhydrazine was added at the concentration of 1 mM. Control flasks were identical to the experimental 
flasks except hat no phenylhydrazine, or no lysate, or neither were added. A dialysis tube containing 4 ml of buffer was introduced into the flask 
at the start of the incubation. The incubation was carried out at 37°C in air for 3 h. At the end of the incubation the concentrations of 
DFO-chelatable iron (‘free iron’) outside and inside the dialysis tube (d.t.) were evaluated. An aliquot of the content of the dialysis tube was added 
to erythrocyte ghosts or to liver or brain microsomes to have a protein concentration of 1 .O mg/ml. The mixture was incubated for 60 min at 37”C, 
and TBARS formation was evaluated. Where indicated DFO (35 PM) was added to the content of the dialysis tube before the latter was added 
to ghosts or microsomes. The values represent he mean f S.E.M. of four experiments. 
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Lipid peroxidation was also seen when liver or brain 
microsomes were used as a target system for the re- 
leased iron instead of ghosts (Table I). These findings 
indicate that iron released into the lysate by phenylhy- 
drazine is able to diffuse into a dialysis tube and to 
induce lipid peroxidation in cellular membranes. The 
addition of DFO to the dialysate, prior to its incubation 
with the membranes prevented, as expected, lipid perox- 
idation (Table I). 
Since in the above experiments less than the half of 
the released iron diffused into the dialysis tube, the 
possibility to increase iron diffusion was verified by 
adding iron chelators to the lysate from the beginning 
of the incubation. As shown in Table II, both DFO and 
NTA increased the diffusion of iron into the dialysis 
tube. A small increase was also observed in the amount 
of free iron detectable in the lysate. These results suggest 
that the released iron, is more readily transported to 
other loci when it is chelated to iron chelators. It is 
possible that even in the absence of externally added 
iron chelators, iron is transported in small complexes. 
Table II also shows that when DFO was used as iron 
chelator no lipid peroxidation was observed in ghosts 
or microsomes subsequently added to the dialysate. 
Whereas with NTA lipid peroxidation developed in the 
membranes, and protein aggregation was also seen. It 
is known in fact, that as the NTA iron complex, iron is 
maintained in a redox active form [ 17,181. 
In further experiments we investigated whether some 
physiological iron chelator acts like NTA in increasing 
iron diffusion and in maintaining the metal in a redox 
active form. Since it is known [ 191 that pyridine nucleo- 
tides readily bind iron and since it has been suggested 
[20,21] that ATP-bound iron is one of the major constit- 
uents of the low molecular weight iron pool, the effects 
of ATP were studied. As shown in Table III, when ATP 
(1.5 mM) was added to the lysate, an increase was seen 
both in free iron present in the lysate and in its diffusion 
into the dialysis tube as compared to the experiments 
(Table I) carried out in the absence of either ATP or 
other chelators. The time course of this diffusion is 
shown in Fig. 1. Moreover, when ghosts or microsomes 
were incubated with the dialysate (Table III) the extent 
of lipid peroxidation was much higher than that seen in 
Table II 
Diffusion of iron (‘free iron’) released from a ghost-free erythrocyte lysate incubated with phenylhydrazine (Phz) in the presence of mtrilotriacetate 
(NTA) or desferrioxamine (DFO), and lipid peroxldation in cellular membranes subsequently added to the dialysate 
Conditions ‘Free iron’ 
(nmol/ml) 
Outside 
d.t. 
Inside 
d.t. 
TBARS 
produced by 
Ghosts 
(nmol/mg Pt) 
60 min 
TBARS 
produced by 
Liver 
Microsomes 
(nmol/mg Pt) 
60 min 
TBARS 
produced by 
Brain 
Microsomes 
(nmol/mg Pt) 
60 min 
Lysate alone 1.1 k 0.2 0.9 f 0.2 0.8 1.1 1.0 
Lysate + Phz 13.6 f 3.5 4.1 f 1.0 5.8 5.4 8.2 
Lysate + Phz + 100 PM NTA 18.1 f 0.7 12.7 !I 0.9 5.0 6.7 8.6 
Lysate + 1 mM Phz + 35 ,uM DFO 19.9 f 1.1 14.8 + 2.1 0.7 0.9 1.0 
Conditions as in Table I except that NTA or DFO were added to the ghost-free erythrocyte lysate since the beginning of the incubation. The values 
reported for ‘Free iron’ represent the mean + S.E.M. of three experiments. The values reported for lipid peroxidation (TBARS) represent the mean 
of two experiments. 
Table III 
Lipid peroxidation (TBARS) in erythrocyte ghosts, liver and brain microsomes exposed to diffusible Iron (‘free iron’) released from a ghost-free 
erythrocyte lysate by phenylhydrazme (Phz) in presence of exogenous ATP 
Conditions MetHb 
(nmol/ml) 
180 min 
Free iron TBARS produced TBARS produced TBARS produced 
(nmol/ml) by Ghosts by Liver by Brain 
(nmol/mg Pt) Microsomes Microsomes 
Outside Inside 60 min (nmol/mg Pt) (nmol/mg Pt) 
d.t. d.t. 60 min 60 min 
No additions (control) _ 0.6 f 0.1 0.5 f 0.1 I.0 f 0.2 1.9 + 0.5 1.3 + 0.7 
+ Lysate - Phz (control) 41.8 + 6.8 0.8 + 0.2 1.1 ?I 0.3 1.5 f 0.8 1.2 t 0.8 0.7 + 0.5 
- Lysate + Phz (control) _ 1.3 f 0.3 1.2 * 0.2 2.3 + 0.3 1.8 + 0.1 0.6 f 0.1 
+ Lysate + Phz (Experim) 1041.1 + 80.7 26.2 f. 4.3 13 3 f 4.3 15.8 + 1.7 13.4 f 1.6 12.9 k 1.3 
+ Lysate + Phz (Experim) + DFO 1041.1 f 80.7 26.2 + 4.4 13.3 * 2.5 1 .O + 0.08 0.9 f 0.08 1.4 f 0.3 
Conditions were as in Table I except that 1.5 mM ATP was added to the ghost-free erythrocyte lysate from the beginning of the Incubation. The 
values reported represent the mean f S.E.M. of four experiments. 
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Fig. 1. Time-course of iron diffusion (DFO-chelatable iron) into a 
dialysis tube dipped in a ghost-free erythrocyte lysate incubated with 
phenylhydrazine (1 mM), in the absence (n--o) or in the presence 
(w-m) of exogenous ATP (1.5 mM). The values represent the mean 
of two experiments. 
the experiments carried out in the absence of ATP. Also, 
lipid peroxidation was higher than in the experiments 
with NTA, notwithstanding that amount of free iron 
detectable in the lysate and in the dialysate was quite 
comparable. 
The effectiveness of ATP in maintaining iron in a 
DFO-chelatable form is shown in Fig. 2. As can be seen, 
the recovery of iron as a DFO-iron complex from a 
solution of ferrous ammonium sulphate in the incuba- 
tion buffer is about 100% in the presence of ATP and 
only about 40% in the absence of it. Probably the inter- 
action of iron with ATP prevents the formation of insol- 
uble hydroxylated iron forms. In the erythrocyte lysate, 
in the absence of externally added ATP, there is very 
likely a loss of released iron and a lower formation of 
complexes capable to cross the dialysis membrane. 
Fig. 3 shows that a prolonged incubation of a ghost- 
free erythrocyte lysate under aerobic conditions results 
in the release of iron even in the absence of the oxidizing 
agent phenylhydrazine. However, the amount of re- 
leased iron after 48 h of incubation is much lower than 
that released after 3 h in the presence of phenylhy- 
drazine. No iron release was seen when the lysate was 
incubated in anaerobic conditions, suggesting again the 
involvement of oxidative stress in the release of iron. 
4. DISCUSSION 
Consistent with our previous report [8], it is shown 
here that when an erythrocyte lysate is subjected to an 
oxidative stress such as that induced by phenylhy- 
drazine, iron is released in a ‘free’ form which is DFO- 
chelatable. Such iron is capable of crossing a dialysis 
membrane and can be recovered in the dialysate. More- 
over, the diffused iron is in a redox active form as shown 
by its ability to initiate lipid peroxidation in cellular 
membranes, such as ghosts or microsomes from liver 
and brain. The accomplishment of a compartmentaliza- 
tion of the two systems - one represented by the lysate 
plus phenylhydrazine as iron releasing system, and the 
other represented by ghosts or microsomes as target 
system - clearly shows that iron, once released from 
hemoglobin is capable of inducing pathological effects 
at distant loci. Thus iron released from iron complexes 
may act as a multiplying factor as to the damage in- 
duced by oxidative stress. Not only can it act on the 
membranes of the cells in which it is released (as previ- 
ously reported in [S]), but it may also diffuse from these 
cells and initiate oxidative reactions in membranes of 
surrounding cells. In an in vivo situation, it can be 
envisaged that iron released from hemoglobin oxidation 
after hemorrhagic accidents, induces oxidative altera- 
tions in surrounding tissues, thus amplifying the dam- 
age due to the hemorrhagic events. It is known that 
hemoglobin potentiates tissue injuries when, for any 
reason, cells are exposed to free hemoglobin [22-241. 
Another interesting result in the present report is that 
physiological iron chelators such as ATP can increase 
iron diffusion and can maintain iron in a redox active 
form capable of initiating oxidative reactions at a dis- 
tance. When the lysate was incubated with ATP, in fact, 
lipid peroxidation in the membranes subsequently 
added to the dialysate was increased and the increase 
was roughly proportional to the increase in iron diffu- 
sion. With NTA on the other hand, the diffusion of iron 
was comparable to that seen with ATP, but the level of 
lipid peroxidation was much lower. It did not increase 
even when different amounts of NTA (25-50 PM) were 
+ATP -ATP 
Fig. 2. Percent recovery of iron from a buffer solution in absence or 
in presence of 2 mM ATP. Ferrous ammonium sulphate was dissolved 
in 0.01 M Tris-maleate buffer, pH 7.4, at the concentration of 20pM. 
The solution was kept at 37°C in air for 3 h. After addition of 35 PM 
DFO, iron concentration was determined as Fe-DFO complex by 
HPLC. The values represent the means f S.E.M. of three experiments. 
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Fig. 3. Iron release (DFO-chelatable iron) in a ghost-free rythrocyte 
lysate during aerobic (m-m) or anaerobic (n-n) incubation at 37°C 
for 48 h. The values represent he mean of two experiments. 
used. It seems therefore that the ATP-iron complex is 
in a form more active for redox cycling than the com- 
plex with NTA. Experiments (not shown here) indicated 
that the iron released in our experimental conditions is 
in the 3+ form, thus unsuitable to be redox active as 
NTA-chelate in the absence of any added reducing 
agent. 
It is possible that when iron is released by phenylhy- 
drazine during the incubation of whole erythrocytes, as 
seen in our former experiments [8], it is rapidly bound 
by ATP whose intracellular concentration is about 2 
mM. This concentration remains high during the first 
15 min of incubation with phenylhydrazine (data not 
shown) when iron release is almost maximal [S]. 
During the hypotonic lysis of the erythrocytes, as 
performed in the experiments here reported, the concen- 
tration of ATP rapidly drops to about one-half; the 
addition of 1.5 mM ATP to the lysate restores the ratio 
ATP/iron released as seen during the incubation of 
whole erythrocytes with phenylhydrazine. It is possible, 
therefore, that a high concentration of ATP needs to be 
present when iron is released and that the immediate 
chelation of iron preserves it in an active form capable 
of initiating lipid and protein oxidation. 
The targets for the iron released in an active form 
could be not only lipids and proteins of cellular mem- 
branes but also other biological important molecules. 
Recent studies have shown that iron can interact with 
DNA and that low molecular weight iron chelates are 
effective in producing DNA damage [25-281. DNA 
strand breakage as well as modifications of DNA bases 
can occur [29-3 I]. It is well known, for instance, that the 
risk for cancer and fibrosis is increased in conditions of 
iron overload, such as hemochromatosis or porphyria 
cutanea tarda [32-351. 
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